Speaker illustration

Doctor David Antonio Chipayo Gonzales

San Carlos Clinical Hospital, Madrid (Spain)

Member of:

European Society of Cardiology

Impact of SGLT2 inhibitor on mortality and cardiovascular outcomes in patients with type 2 diabetes mellitus with left main or multivessel coronary artery disease

Event: ESC Congress 2022

Topic: Antidiabetic Pharmacotherapy

Session: SGLT2 inhibitors in clinical practice

Thumbnail

This platform is supported by

logo Novo Nordisk